National Bowel Cancer Screening Program

Endoscopy

Useful Management Information

  • For your patients, you are asked to:
    • encourage those who are sent a screening test and for whom the test is clinically relevant, to participate.
    • assess those with a positive result and refer them for further examination as clinically indicated, for example a colonoscopy. The National Health and Medical Research Council (NHMRC) approved Guidelines  state that participants with positive iFOBT results should have follow-up investigation unless there was a clear breach in protocol when samples were collected (e.g. menstrual blood loss close to the time of sample collection) and that colonoscopy should be performed as promptly as possible after a positive iFOBT to minimise the risk of psychological harm, although there is no evidence that prognosis is worsened within 120 days if cancer is present.
    • indicate whether a patient referred for colonoscopy is a Program participant to assist with reporting to the Program Register.
    • notify the Program Register of referral/non-referral for colonoscopy or other bowel examination for participants with a positive result. This can be done by returning the Program’s GP Assessment Form by fax, post or electronically. 
    • inform patients at average risk, or slightly above, that the NHMRC approved Guidelines recommend screening every two years, starting at age 50 years and continuing to age 74 years
    • manage patients identified as being at increased risk of bowel cancer in accordance with the NHMRC approved Guidelines .
    • manage patients (of any age) with symptoms in accordance with the NHMRC approved Guidelines, in recognition that bowel cancer can occur at any age.

Clinical Resources

Minimum Referral Criteria

Category 1
  • iFOBT positive in patients ≥ 50- 74 years old
Category 2
  • No category 2 criteria
Category 3
  • No category 3 criteria

If your patient doesn't meet the minimum referral criteria

  • Consider other treatment pathways or an alternative diagnosis
  • If the patient does not meet the criteria for referral but the referring practitioner believes the patient requires specialist review, a clinical override may be requested:
    • Please explain why (e.g. warning signs or symptoms, clinical modifiers, uncertain about diagnosis, etc.)
  • Please note that your referral may not be accepted or may be redirected to another service.

Essential Referral Information

  • NBCSP results - showing positive FOBT result
  • NBCSP ID number
  • Patient and family history of bowel cancer
  • Medical and surgical history
  • Current medications (if relevant)

If a specific test result is unable to be obtained due to access, financial, religious, cultural or consent reasons a Clinical Override may be requested. This reason must be clearly articulated in the body of the referral.

Additional Referral Information

  • No additional referral information
Published 9 April 2021

Send Referrals To

Smart Referrals

Coming Soon

Internal Referrals

Not available

Fax

5687 4497

Post

Booking and Referral Centre
Gold Coast University Hospital
1 Hospital Boulevard
Southport QLD 4215

Enquiries

1300 559 083

Service Availability

Facilities

Gold Coast University Hospital

If you would like to send a named referral, please address it to the specialist listed above, who will allocate a suitably qualified specialist to see the patient. Alternatively, you can view a full list of our specialists.

Gold Coast Health - For Clinicians
© The State of Queensland 1995-2021 | Queensland Government
Queensland Government acknowledges the Traditional Owners of the land and pays respect to Elders past, present and future.